Letters
Hormone replacement therapy
Irresponsible to modify current guidelines
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1494 (Published 03 September 2008) Cite this as: BMJ 2008;337:a1494
- Ellen C G Grant, physician and medical gynaecologist1
- 1Kingston upon Thames KT2 7JU
- ellengrant{at}talktalk.net
In the WISDOM hormone replacement therapy (HRT) trial, overall health related quality of life measures were reduced at four and 14 weeks of HRT use rather than increased (see table 4).1 Data were …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.